🇺🇸 FDA
Pipeline program

Arbaclofen Placarbil

RB-US-14-0001

Phase 2 small_molecule completed

Quick answer

Arbaclofen Placarbil for Alcohol Use Disorder is a Phase 2 program (small_molecule) at Indivior Europe Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Europe Limited
Indication
Alcohol Use Disorder
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials